TRxADE Health still unable to file Q1 10-Q, faces potential Nasdaq compliance issue

Scienture Holdings, Inc.

Filed Form 12b-25 on May 15, but still unable to file Q1 10-Q for period ended March 31, 2024.
Non-compliance with Nasdaq Listing Rule 5250(c)(1) for timely periodic financial reports.
Believes stockholders' equity exceeds $2.5M as of March 31, 2024 due to proceeds from asset sale of Trxade, Inc.
Company remains under Panel Monitor for equity compliance through August 30, 2024.
No assurances on timing for filing Form 10-Q; working diligently to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.